Kronos Bio, Inc. Contracts & Agreements
22 Contracts & Agreements
- Business Finance (7 contracts)
- Business Operations (1)
- Human Resources (9)
- Real Estate (1)
- Uncategorized (4)
- Separation Agreement, by and between the registrant and Barbara Kosacz, dated January 24, 2024 (Filed With SEC on March 21, 2024)
- Separation Agreement, by and between the registrant and Jorge DiMartino, M.D., Ph.D., dated January 24, 2024 (Filed With SEC on March 21, 2024)
- Consulting Agreement by and between the Company and FLG Partners, LLC, dated September 8, 2023 (Filed With SEC on November 13, 2023)
- Collaboration and License Agreement between the registrant and Genentech, Inc. and F. Hoffmann-La Roche Ltd., dated January 6, 2023 (Filed With SEC on March 15, 2023)
- Description of Registrants Common Stock (incorporated by reference to Exhibit 4.4 to the registrants Annual Report on Form 10-K (File No. 001-39592), filed with the SEC on... (Filed With SEC on March 15, 2023)
- Kronos Bio, Inc. Severance and Change in Control Plan with amended form of Participation Agreement thereunder (Filed With SEC on August 4, 2022)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on August 4, 2022)
- Kronos Bio, Inc. Severance and Change in Control Plan (Filed With SEC on April 21, 2022)
- Non-Employee Director Compensation Policy (incorporated by reference to Exhibit 10.12 to the registrants Registration Statement on Form S-1 (File No. 333-248925), as amended,... (Filed With SEC on February 24, 2022)
- Description of Registrants Common Stock (Filed With SEC on February 24, 2022)
- Second Amendment to Office Lease, dated February 8, 2021, by and between Kronos Bio, Inc. and MPVCA San Mateo LLC (Filed With SEC on May 11, 2021)
- Letter of Agreement, by and between the registrant and Christopher Dinsmore, Ph.D., dated May 29, 2020 (Filed With SEC on March 23, 2021)
- Description of Registrants Common Stock (Filed With SEC on March 23, 2021)
- Letter of Agreement, by and between the registrant and Barbara Kosacz, dated July 15, 2020 (Filed With SEC on November 18, 2020)
- Non-Employee Director Compensation Policy (Filed With SEC on October 5, 2020)
- Letter Agreement, by and between the registrant and Norbert Bischofberger, Ph.D., dated April 30, 2018 (Filed With SEC on October 5, 2020)
- Kronos Bio, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on October 5, 2020)
- Kronos Bio, Inc. 2020 Equity Incentive Plan, and Forms of Option Grant Notice, Option Agreement, Notice of Exercise, Restricted Stock Unit Grant Notice and Restricted Stock Unit... (Filed With SEC on October 5, 2020)
- Form of Indemnity Agreement, by and between the registrant and its directors and officers (Filed With SEC on October 5, 2020)
- Form of Common Stock Certificate of the registrant (Filed With SEC on October 5, 2020)
- Form of Underwriting Agreement (Filed With SEC on October 5, 2020)
- Asset Purchase Agreement, by and between the registrant and Gilead Sciences, Inc., dated July 14, 2020 (Filed With SEC on September 18, 2020)
